# Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults

> **NCT01575288** · NA · COMPLETED · sponsor: **University of Colorado, Boulder** · enrollment: 110 (actual)

## Conditions studied

- Vascular Aging

## Interventions

- **DRUG:** Placebo
- **DRUG:** High-dose trehalose

## Key facts

- **NCT ID:** NCT01575288
- **Lead sponsor:** University of Colorado, Boulder
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2015-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01575288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01575288, "Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01575288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*